h-header

news

News from the world

02

Dec

Lonza sells Micro-Macinazione site in Switzerland to CDMO Microsize and Schedio Group

Microsize, a U.S.-based contract development and manufacturing organization (CDMO) specializing in particle size reduction and control technologies, has signed an agreement to acquire from Lonza its Micro-Macinazione (Mic Mac) dedicated micronization facility in Monteggio, Switzerland.

Under the deal for an undisclosed amount, Schedio Group — a Swiss-based provider of jet mills, isolators, spray dryers, and engineering services — is also investing with Microsize to strengthen and localize its operational base in Europe, according to the announcement. Both companies will invest in Mic Mac to boost its capabilities and hasten modernization...[PharmaManufacturing]

22

Dec

Massiccio reshoring farmaceutico negli Stati Uniti

Large pharmaceutical companies have promised to invest more than $370 billion over the next five years...

17

Dec

EU health sector: New measures to make it more innovative, competitive and resilient

The European Commission has proposed an ambitious package of measures to improve the health of EU...

12

Dec

EMA finalizes guideline on developing and manufacturing synthetic peptides

EMA has published a final guideline on synthetic peptide development and manufacture. The text will take...

12

Dec

Riforma farmaceutica EU: Parlamento e Consiglio UE hanno trovato l'intesa

Parlamento e Consiglio UE hanno trovato l'intesa sulla riforma farmaceutica: un nuovo sistema di...

slider-banner

h-footer